Preparing for HPV vaccination in South Africa: Key challenges and opinions

Harries, Jane; Moodley, Jennifer; Barone, Mark A.; Mall, Sumaya; Sinanovic, Edina

doi:10.1016/j.vaccine.2008.10.033

Cited by 83 publications

(103 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Other studies in South Africa, Ghana and Tanzania reported the same. 24,29,30 Therefore, it is important to educate people regarding the side effects and effectiveness of the vaccines through the media and through health care workers as they are the most trusted people when it comes to health issues.…”

Section: Discussionmentioning

confidence: 99%

Acceptability of human papillomavirus vaccination among academics at the University of KwaZulu-Natal, South Africa

Hoque

2015

South African Family Practice

View full text Add to dashboard Cite

Background:The South African Government has recently implemented the human papillomavirus (HPV) vaccination programme through the school health system. For the vaccination programme to be effective, it is important to investigate the acceptability of the vaccines among university academics. The objective of this study was to determine the awareness and acceptability of HPV vaccination among university academics, and to investigate whether health information increases the acceptability of the vaccines. Materials and methods: This was a cross-sectional study conducted among academics from the University of KwaZulu-Natal -excluding medical school academics. Data were collected using a self-administered anonymous questionnaire, via an online survey. Results: It was found that most academics were aware of cervical cancer and HPV infections. The health information regarding HPV infections and vaccines had significantly increased the acceptance of HPV vaccine for their daughters (79% to 88%, p < 0.05). There was a knowledge gap regarding the safety and effectiveness of the vaccines. Conclusion: University academics need to be educated on this preventable disease so that they can provide accurate information to their students, who are in the high-risk population for cervical cancer.

show abstract

Section: Discussionmentioning

confidence: 99%

Acceptability of human papillomavirus vaccination among academics at the University of KwaZulu-Natal, South Africa

Hoque

2015

South African Family Practice

View full text Add to dashboard Cite

show abstract

“…32 This engagement is an important component of program success, given that many women and their families have limited understanding of cervical cancer or of the availability of simple interventions to prevent it. [35][36][37][38] Ensuring that accurate and understandable information is available, through mechanisms and formats that are culturally acceptable, should be part of any cervical cancer prevention program.…”

Section: Discussionmentioning

confidence: 99%

Evidence-Based, Alternative Cervical Cancer Screening Approaches in Low-Resource Settings

Sherris¹,

Wittet²,

Kleine³

et al. 2009

IPSRH

Self Cite

105

View full text Add to dashboard Cite

Cervical cancer kills approximately 270,000 women worldwide each year, with nearly 85% of those deaths occurring in resource-poor settings. 1 Use of the Pap smear for routine screening of women has resulted in a dramatic decline in cervical cancer deaths over the past four decades in wealthier countries. A key reason for continuing high mortality in the developing world is the shortage of efficient, high-quality screening programs in those regions.In 1999, five international health organizations came together to create the Alliance for Cervical Cancer Prevention (ACCP).* For the next eight years, with support from the Bill & Melinda Gates Foundation, the partners worked on a coordinated research agenda aimed at assessing a variety of approaches to cervical cancer screening and treatment (especially ones that may be better suited to low-resource settings), improving service delivery systems, ensuring that community perspectives and needs are incorporated into program design, and increasing awareness of cervical cancer and effective prevention strategies. Several outstanding issues were identified at that time. A general issue was a lack of consensus about the most effective and feasible options for improving cancer screening and treatment. Specific issues included uncertainty about the impact of simple screening methods and a screen-and-treat approach on cervical cancer incidence and mortality; the comparative performance of visual inspection methods of screening-visual inspection with acetic acid (VIA) or Lugol's iodine (VILI) † -and new methods using human papillomavirus (HPV) DNA testing; the optimal ways to reduce false-positive results from visual inspection methods without producing more false-negatives; and any possible links between the use of cryotherapy and subsequent HIV acquisition.Recent studies and analyses have answered some of these questions and have validated earlier findings related to safe, effective, operationally feasible and culturally appropriate strategies for secondary prevention of cervical cancer. ‡ On the basis of these new data and the results of earlier research conducted in 20 African, Asian and Latin American countries, the ACCP partners have summarized and shared key findings and recommendations for effective cervical cancer screening and treatment programs in low-resource settings, as follows. FINDINGS•In low-resource settings, the optimal age-group for cervical cancer screening to achieve the greatest public health impact is 30-39-year-olds. Screening is considered optimal when the smallest amount of resources is used to achieve the greatest benefit. To determine the optimal age for cervical cancer screening, ACCP researchers used two methodologies: modeling and field-based study. Goldie et al. 2 conducted cost-effectiveness modeling comparing screening strategies in five developing countries. Their model predicted that for 35-year-old women screened only once in their life, a single-visit or two-visit approach with the VIA method could reduce the lifetime risk of cervical canc...

show abstract

“…The findings were also important in informing policy development of programs to support HPV vaccination in South Africa and other African countries. 24 …”

Section: Justification Of Routine Hpv Vaccination For Ghanamentioning

confidence: 99%

Is routine human papillomavirus vaccination an option for Ghana?

Edwin¹

2011

Ghana Medical Journal

View full text Add to dashboard Cite

Preparing for HPV vaccination in South Africa: Key challenges and opinions

Cited by 83 publications

References 25 publications

Acceptability of human papillomavirus vaccination among academics at the University of KwaZulu-Natal, South Africa

Acceptability of human papillomavirus vaccination among academics at the University of KwaZulu-Natal, South Africa

Evidence-Based, Alternative Cervical Cancer Screening Approaches in Low-Resource Settings

Is routine human papillomavirus vaccination an option for Ghana?

Contact Info

Product

Resources

About